Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.42 USD | -0.21% |
|
-0.62% | -1.64% |
Jun. 09 | Nature's Sunshine Products files for offering of 2.8 mln shares | RE |
Jun. 02 | Terrence Moorehead to Step Down as Chief Executive Officer of Nature?s Sunshine Products, Inc | CI |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.81 | 8.52 | 4.16 | 6.37 | 5.12 | |||||
Return on Total Capital | 7.91 | 11.78 | 5.8 | 8.97 | 7.18 | |||||
Return On Equity % | 16.02 | 18.96 | 0.36 | 10.71 | 4.92 | |||||
Return on Common Equity | 14.99 | 18.4 | -0.26 | 10.15 | 4.98 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 73.71 | 74 | 71.05 | 72.11 | 71.46 | |||||
SG&A Margin | 68.13 | 66.19 | 67.19 | 66.62 | 67.04 | |||||
EBITDA Margin % | 8.37 | 10.32 | 6.47 | 8.14 | 7.55 | |||||
EBITA Margin % | 5.58 | 7.81 | 3.85 | 5.49 | 4.42 | |||||
EBIT Margin % | 5.58 | 7.81 | 3.85 | 5.49 | 4.42 | |||||
Income From Continuing Operations Margin % | 5.96 | 6.8 | 0.13 | 3.69 | 1.74 | |||||
Net Income Margin % | 5.54 | 6.5 | -0.09 | 3.39 | 1.69 | |||||
Net Avail. For Common Margin % | 5.54 | 6.5 | -0.09 | 3.39 | 1.69 | |||||
Normalized Net Income Margin | 3.26 | 4.16 | 2.05 | 3.31 | 2.49 | |||||
Levered Free Cash Flow Margin | 8.22 | 4.9 | -1.71 | 8.88 | 3.88 | |||||
Unlevered Free Cash Flow Margin | 8.23 | 4.93 | -1.67 | 8.89 | 3.9 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.67 | 1.75 | 1.73 | 1.86 | 1.85 | |||||
Fixed Assets Turnover | 4.88 | 6.18 | 6.42 | 7.38 | 8.21 | |||||
Receivables Turnover (Average Receivables) | 52.43 | 54.67 | 36.72 | 38.84 | 49.65 | |||||
Inventory Turnover (Average Inventory) | 2.15 | 2.13 | 1.9 | 1.84 | 2.05 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.21 | 2.15 | 2.28 | 2.16 | 2.44 | |||||
Quick Ratio | 1.43 | 1.24 | 1.13 | 1.19 | 1.43 | |||||
Operating Cash Flow to Current Liabilities | 0.54 | 0.45 | 0.01 | 0.54 | 0.39 | |||||
Days Sales Outstanding (Average Receivables) | 6.98 | 6.68 | 9.94 | 9.4 | 7.37 | |||||
Days Outstanding Inventory (Average Inventory) | 170.48 | 171.54 | 192.44 | 198.15 | 178.29 | |||||
Average Days Payable Outstanding | 19.49 | 22.97 | 22.66 | 21.13 | 25.19 | |||||
Cash Conversion Cycle (Average Days) | 157.98 | 155.25 | 179.71 | 186.42 | 160.47 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 16.74 | 14.24 | 13.05 | 9.35 | 8.82 | |||||
Total Debt / Total Capital | 14.34 | 12.47 | 11.54 | 8.55 | 8.11 | |||||
LT Debt/Equity | 11.98 | 10.59 | 9.35 | 6.5 | 6.38 | |||||
Long-Term Debt / Total Capital | 10.26 | 9.27 | 8.27 | 5.95 | 5.87 | |||||
Total Liabilities / Total Assets | 36.98 | 37.65 | 36 | 36.13 | 33.16 | |||||
EBIT / Interest Expense | 210.61 | 138.68 | 65.29 | 354.33 | 137.64 | |||||
EBITDA / Interest Expense | 384.56 | 209.73 | 135.67 | 615.43 | 279.55 | |||||
(EBITDA - Capex) / Interest Expense | 336.47 | 183.06 | 105.04 | 463.58 | 204.4 | |||||
Total Debt / EBITDA | 0.67 | 0.44 | 0.57 | 0.35 | 0.35 | |||||
Net Debt / EBITDA | -1.68 | -1.21 | -1.21 | -1.59 | -1.73 | |||||
Total Debt / (EBITDA - Capex) | 0.77 | 0.5 | 0.73 | 0.47 | 0.48 | |||||
Net Debt / (EBITDA - Capex) | -1.92 | -1.38 | -1.56 | -2.11 | -2.36 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 6.35 | 15.29 | -4.99 | 5.55 | 2.03 | |||||
Gross Profit, 1 Yr. Growth % | 5.84 | 15.74 | -8.78 | 7.13 | 1.11 | |||||
EBITDA, 1 Yr. Growth % | 20.58 | 42.22 | -40.47 | 32.92 | -2.97 | |||||
EBITA, 1 Yr. Growth % | 33.22 | 61.39 | -53.11 | 50.38 | -14.67 | |||||
EBIT, 1 Yr. Growth % | 33.22 | 61.39 | -53.11 | 50.38 | -14.67 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 231.33 | 31.58 | -98.18 | 2.88K | -51.92 | |||||
Net Income, 1 Yr. Growth % | 215.4 | 35.23 | -101.35 | -3.97K | -48.95 | |||||
Normalized Net Income, 1 Yr. Growth % | 32.71 | 46.93 | -53.06 | 70.27 | -20.76 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 214.71 | 32.71 | -101.42 | -3.92K | -48.05 | |||||
Accounts Receivable, 1 Yr. Growth % | 0.77 | 20.28 | 59.01 | -37.42 | 7.36 | |||||
Inventory, 1 Yr. Growth % | 2.18 | 27.62 | 11.66 | -1.55 | -11.14 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -10.66 | -7.19 | -9.97 | -6.33 | -10.24 | |||||
Total Assets, 1 Yr. Growth % | 17.1 | 3.76 | -11.24 | 8.7 | -3.57 | |||||
Tangible Book Value, 1 Yr. Growth % | 20.26 | 1.81 | -9.67 | 7.8 | 0.81 | |||||
Common Equity, 1 Yr. Growth % | 20.26 | 1.81 | -9.67 | 7.8 | 0.81 | |||||
Cash From Operations, 1 Yr. Growth % | 340.71 | -8.1 | -97.95 | 5.71K | -38.64 | |||||
Capital Expenditures, 1 Yr. Growth % | -3.9 | 35.9 | 14.43 | 37.36 | 4.7 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 1.77K | -26.92 | -136.77 | -843.62 | -54.8 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 1.75K | -26.55 | -135.69 | -866.86 | -54.62 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.76 | 10.73 | 4.66 | 0.14 | 3.77 | |||||
Gross Profit, 2 Yr. CAGR % | 2.71 | 10.68 | 2.75 | -1.15 | 4.07 | |||||
EBITDA, 2 Yr. CAGR % | 35.48 | 30.96 | -7.99 | -11.05 | 12.15 | |||||
EBITA, 2 Yr. CAGR % | 65.42 | 46.63 | -13 | -16.02 | 11.18 | |||||
EBIT, 2 Yr. CAGR % | 66.48 | 46.63 | -13 | -16.02 | 11.18 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 337.03 | 108.79 | -84.52 | -26.28 | 278.8 | |||||
Net Income, 2 Yr. CAGR % | 399.85 | 106.52 | -86.48 | -27.72 | 344.22 | |||||
Normalized Net Income, 2 Yr. CAGR % | 79.48 | 39.64 | -16.95 | -10.6 | 14.27 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 389.49 | 104.36 | -86.27 | -26.36 | 345.21 | |||||
Accounts Receivable, 2 Yr. CAGR % | -2.46 | 10.09 | 38.3 | -0.25 | -18.03 | |||||
Inventory, 2 Yr. CAGR % | 6.49 | 14.19 | 19.37 | 4.85 | -6.47 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.89 | -8.94 | -8.59 | -8.17 | -8.31 | |||||
Total Assets, 2 Yr. CAGR % | 13.69 | 10.23 | -4.03 | -1.77 | 2.38 | |||||
Tangible Book Value, 2 Yr. CAGR % | 13.85 | 10.65 | -4.1 | -1.32 | 4.25 | |||||
Common Equity, 2 Yr. CAGR % | 13.55 | 10.65 | -4.1 | -1.32 | 4.25 | |||||
Cash From Operations, 2 Yr. CAGR % | 31.33 | 101.25 | -86.27 | 9.14 | 496.92 | |||||
Capital Expenditures, 2 Yr. CAGR % | 0.73 | 14.28 | 24.71 | 25.37 | 19.93 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 7.94 | 258.84 | -50.73 | 41.93 | 82.03 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 7.57 | 257.3 | -51.32 | 41.45 | 85.22 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.04 | 6.77 | 5.22 | 4.95 | 0.77 | |||||
Gross Profit, 3 Yr. CAGR % | 4.2 | 6.88 | 3.77 | 4.19 | -0.4 | |||||
EBITDA, 3 Yr. CAGR % | 47.6 | 37.69 | 0.69 | 4.02 | -9.2 | |||||
EBITA, 3 Yr. CAGR % | 138.32 | 64.06 | 0.27 | 4.41 | -16.62 | |||||
EBIT, 3 Yr. CAGR % | 149.27 | 64.77 | 0.27 | 4.41 | -16.62 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 18.44 | 192.91 | -57.02 | -10.58 | -36.07 | |||||
Net Income, 3 Yr. CAGR % | 18.13 | 223.28 | -61.37 | -10.93 | -35.63 | |||||
Normalized Net Income, 3 Yr. CAGR % | 65.88 | 67.9 | -2.91 | 5.5 | -15.06 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 15.75 | 216.81 | -60.99 | -10.39 | -34.45 | |||||
Accounts Receivable, 3 Yr. CAGR % | -6.03 | 4.6 | 24.45 | 6.17 | 2.23 | |||||
Inventory, 3 Yr. CAGR % | 2.68 | 13.11 | 13.34 | 11.95 | -0.78 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 2.57 | 2.61 | -9.28 | -7.84 | -8.87 | |||||
Total Assets, 3 Yr. CAGR % | 8.53 | 10.28 | 2.55 | 0.04 | -2.38 | |||||
Tangible Book Value, 3 Yr. CAGR % | 9.42 | 9.68 | 3.42 | -0.29 | -0.61 | |||||
Common Equity, 3 Yr. CAGR % | 9.2 | 9.5 | 3.42 | -0.29 | -0.61 | |||||
Cash From Operations, 3 Yr. CAGR % | 52.95 | 16.6 | -56.36 | 3.06 | -9.92 | |||||
Capital Expenditures, 3 Yr. CAGR % | -3.75 | 11.31 | 14.33 | 28.79 | 18.07 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 66.04 | -7.15 | 62.33 | 9.97 | -3.54 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 64.73 | -7.21 | 60.31 | 9.93 | -3.63 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.48 | 5.41 | 4.29 | 4.07 | 4.64 | |||||
Gross Profit, 5 Yr. CAGR % | 3.47 | 5.6 | 3.62 | 3.6 | 3.89 | |||||
EBITDA, 5 Yr. CAGR % | 8.23 | 25.29 | 22.18 | 15.61 | 5.13 | |||||
EBITA, 5 Yr. CAGR % | 4.45 | 27.88 | 59.26 | 25.51 | 4.5 | |||||
EBIT, 5 Yr. CAGR % | 4.57 | 28.13 | 63.61 | 25.83 | 4.5 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 14.75 | 113.88 | -47.52 | 68.68 | 2.64 | |||||
Net Income, 5 Yr. CAGR % | 7.76 | 68.27 | -50.36 | 77.57 | 2.61 | |||||
Normalized Net Income, 5 Yr. CAGR % | 2.51 | 20.68 | 25.78 | 30.48 | 3.63 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.15 | 66.79 | -50.66 | 76.73 | 3.3 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.86 | 2.77 | 9.68 | 2.63 | 5.3 | |||||
Inventory, 5 Yr. CAGR % | 4.37 | 5.04 | 9.06 | 9.73 | 4.96 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 1.64 | -1.14 | -2.05 | -1.85 | -8.9 | |||||
Total Assets, 5 Yr. CAGR % | 4.47 | 4.72 | 3.32 | 5.29 | 2.48 | |||||
Tangible Book Value, 5 Yr. CAGR % | 3.17 | 3.98 | 3.8 | 5.14 | 3.75 | |||||
Common Equity, 5 Yr. CAGR % | 3.08 | 3.83 | 3.67 | 5.04 | 3.75 | |||||
Cash From Operations, 5 Yr. CAGR % | 29.95 | 58.89 | -41.68 | 13.56 | 24.24 | |||||
Capital Expenditures, 5 Yr. CAGR % | -26.28 | -9.58 | 6.76 | 16.73 | 16.54 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 29.61 | 45.68 | 0.87 | 7.81 | 59.87 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 29.91 | 45.8 | -0.08 | 7.64 | 59.53 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions